Pharmafile Logo

Eyeforpharma – Real World Evidence 2018

16-17 May in Tokyo, Japan


Research Partnership is delighted to be attending the Eyeforpharma Real World Evidence (RWE) conference in Tokyo, Japan 16-17 May. RWE is currently a very hot topic for the Japanese pharma industry, with an increased push to place RWE as a strategic imperative for pharma.

Representing Research Partnership is APAC Director, Pei Li Teh who is based in the company’s Asia-Pacific office in Singapore. Find out more: 
https://bit.ly/2rcxf7Q

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Webcast: Virtual Q&A session – The future of digital health

In this webcast, Senior Director, Richard Head and Director of The Medical Futurist, Dr. Bertalan Mesko host a live virtual Q&A discussion about the future of digital health.

Research Partnership is on the rise

Research Partnership ranks 12th in fastest growing UK market research agency league  tables

What does the future hold for Light-chain Amyloidosis?

Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...

Webcast: Securing a future for telehealth with immersive market research insights

Research Partnership investigate the current landscape, the challenges to adoption and the future for telehealth.

Breaking the silence: It’s time to talk about the menopause

Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change.

News:

Senior Analytics Specialist joins Research Partnership

Article:

All change – how untangling human behaviour can encourage better health

Webcast:

Understanding changing digital behaviours: Insights needed for an effective omnichannel strategy

News:

Therapy Watch COVID-19 tracker

Events:

Patient Centricity and Engagement Conference 2021